We are live on ! Find out more
GNPX icon

Genprex

20 hedge funds and large institutions have $1.17M invested in Genprex in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

25% more funds holding

Funds holding: 1620 (+4)

0% less ownership

Funds ownership: 0%0% (-0%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

55% less capital invested

Capital invested by funds: $2.6M → $1.17M (-$1.43M)

Holders
20
Holders Change
+4
Holders Change %
+25%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
1
Reduced
2
Closed
4
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$4K

GNPX Hedge Fund Activity: Q4 2023 in Review

20 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q4 2023, worth a combined $1.17M — down 55% from $2.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new GNPX positions and 4 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $92.3K. The largest seller was CVI Holdings, cutting an estimated $358K.

  • 20 institutional investors held Genprex (GNPX) as of Q4 2023, up from 16 in Q3 2023.
  • Funds reported $1.17M of Genprex stock for Q4 2023, down 55% quarter-over-quarter.
  • 8 funds opened new Genprex positions in Q4 2023 and 4 closed out, a net change of +4 holders.
  • The largest Genprex buyer in Q4 2023 was Renaissance Technologies, an estimated $92.3K added.
  • The largest Genprex seller in Q4 2023 was CVI Holdings, an estimated $358K sold.

Based on aggregated 13F filings for Q4 2023.